NCT05871788View on ClinicalTrials.gov

Biomarkers in Patients With Metastatic Breast Cancer

Not yet recruitingOBSERVATIONAL
Enrollment

1,600

Participants

Timeline

Start Date

June 30, 2023

Primary Completion Date

June 30, 2027

Study Completion Date

December 31, 2027

Conditions
Identify the Number of Eligible Patients for Immunotherapy According to the Epidemiological and Biological Profile in Tunisia
Interventions
DIAGNOSTIC_TEST

identify biomarkers

Identify the epidemiological profile of the biological signature (PD-L1 / TMB / MSI/HRD/ TILs) of patients with locally advanced or metastatic breast carcinoma

All Listed Sponsors
lead

Tunisian Association for Immuno-oncology Research

OTHER

NCT05871788 - Biomarkers in Patients With Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter